BSX vs ORCL · P/E 20, rev $10.65B vs P/E 31, rev $67.36B
Boston Scientific Corp (BSX) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the BSX and ORCL stock pages for the full models.
Not investment advice.